Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (63 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > Really not happy about the price... at all
View:
Post by gojotv! on Sep 22, 2022 10:50pm

Really not happy about the price... at all

Remember when the share price was in the forties and Roger set the financing price at $0.30?
Shareholders were all livid and the stock price tumbled.
So why is everyone acting so happy about this price?
These guys are not supporting the argument that these shares are worth something. I shudder to think how cheaply they'll be willing to sell out if they can get away with it.
Comment by ScienceFirst on Sep 22, 2022 11:07pm
Gojotv ... Market conditions.  Otherwise, why wouldn't they wanted to have a better conditions?  Tell me. Go shop us a better deal.  We'll cancel this one if you find something better. Until we have commercial revenues, we will be at the mercy of sharks.  If we get Brekathrough, that's gonna be a different story as it will mean commercialization is at reach ...more  
Comment by Lesalpes29 on Sep 23, 2022 6:52am
If this PP is the end of the world for you dummy... sell your shares. I'm ready to add some under .25!
Comment by TimboBaggins on Sep 23, 2022 10:07am
Well since you think the buyout will be 150 billion or whatever that still puts the stock at over 700$ a share. Why are you concerned.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

Connect with V.TLT


Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 63 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250